ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,249Medicare Part D Prescriptions Filled, Including Refills

Rank: 22 out of 1000

$1.24M Total Retail Price of All Prescriptions

Rank: 27 out of 1000

868 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 868 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 868 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 19,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 1,167 851 1 2
AMLODIPINE BESYLATE 808 691 2 6
HYDROCODONE-ACETAMINOPHEN 763 436 S3 3 1
LEVOTHYROXINE SODIUM 614 529 4 4
FUROSEMIDE 576 511 5 7
SIMVASTATIN 572 404 6 3
HYDROCHLOROTHIAZIDE 541 446 7 9
POTASSIUM CHLORIDE 480 421 8 10
POLYETHYLENE GLYCOL 3350 479 436 9 69
CARVEDILOL 413 315 10 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 402 290 11 20
GABAPENTIN 390 311 12 11
METFORMIN HCL 378 218 13 8
GLIMEPIRIDE 372 260 14 34
WARFARIN SODIUM 365 320 15 22
ZOLPIDEM TARTRATE 330 144 16 16
CITALOPRAM HBR 322 253 17 17
LISINOPRIL 306 199 18 5
PRAVASTATIN SODIUM 300 167 19 12
METOPROLOL TARTRATE 295 250 20 19
ATORVASTATIN CALCIUM 279 214 21 18
TRAMADOL HCL 274 212 22 13
CLOPIDOGREL 271 234 23 35
NEXIUM 256 177 24 23
METOPROLOL SUCCINATE 246 147 25 21
RANITIDINE HCL 233 144 26 37
AZITHROMYCIN 225 156 27 36
LOSARTAN-HYDROCHLOROTHIAZIDE 218 173 28 38
DONEPEZIL HCL 217 182 29 32
LOSARTAN POTASSIUM 198 165 30 25
PLAVIX 192 160 31 49
MIRTAZAPINE 192 178 31 56
ALLOPURINOL 186 174 33 31
MELOXICAM 171 106 34 14
TRAZODONE HCL 169 111 35 29
AMITRIPTYLINE HCL 169 112 R 35 45
FLUOXETINE HCL 166 114 37 51
LANTUS 165 107 38 68
SERTRALINE HCL 162 87 39 26
ROPINIROLE HCL 161 116 40 82
PAROXETINE HCL 161 108 40 63
GEMFIBROZIL 161 81 40 105
RISPERIDONE 154 129 43 87
CRESTOR 152 130 44 30
ATENOLOL 148 109 45 24
PANTOPRAZOLE SODIUM 144 113 46 28
CYCLOBENZAPRINE HCL 137 54 R 47 39
TAMSULOSIN HCL 137 106 47 33
CLONIDINE HCL 133 99 49 27
ALBUTEROL SULFATE 133 132 49 142
CYMBALTA 133 38 49 53
ISOSORBIDE DINITRATE 131 120 52 224
TORSEMIDE 130 113 53 137
CLOTRIMAZOLE-BETAMETHASONE 128 87 54 173
BISOPROLOL-HYDROCHLOROTHIAZIDE 125 102 55 101
PROAIR HFA 122 60 56 50
HYDRALAZINE HCL 120 113 57 74
AMIODARONE HCL 120 115 57 178
PREDNISONE 118 79 59 42
PHENYTOIN SODIUM EXTENDED 117 69 60 115
METOCLOPRAMIDE HCL 115 70 61 99
IPRATROPIUM BROMIDE 114 111 62 203
MECLIZINE HCL 108 94 63 80
LYRICA 105 61 64 47
NAMENDA 104 94 65 43
SINGULAIR 104 69 65 84
ISOSORBIDE MONONITRATE ER 104 89 65 71
INSULIN SYRINGE 102 78 68 93
AMOX TR-POTASSIUM CLAVULANATE 97 65 69 125
ESCITALOPRAM OXALATE 97 89 69 60
LEVOFLOXACIN 96 80 71 73
VERAPAMIL ER 95 67 72 86
METHYLPREDNISOLONE 95 72 72 103
LOVASTATIN 94 85 74 41
AMLODIPINE BESYLATE-BENAZEPRIL 93 59 75 59
ZETIA 92 50 76 95
LEVEMIR 92 91 76 179
CARBIDOPA-LEVODOPA 91 73 78 116
CIPROFLOXACIN HCL 91 71 78 46
KLOR-CON M20 91 80 78 66
METFORMIN HCL ER 90 64 81 44
FENTANYL 89 72 S2 82 100
NOVOLOG 83 69 83 156
ALENDRONATE SODIUM 83 71 83 57
GLIPIZIDE ER 83 65 83 106
BUPROPION HCL SR 81 52 86 183
GLIPIZIDE 80 73 87 62
MONTELUKAST SODIUM 78 57 88 132
ADVAIR DISKUS 77 51 89 65
BENAZEPRIL HCL 76 57 90 61
METOLAZONE 75 72 91 167
DIOVAN HCT 74 66 92 96
AMOXICILLIN 73 32 93 89
HUMULIN 70-30 72 60 94 131
PROMETHAZINE HCL 71 51 R 95 54
BUPROPION XL 70 33 96 207
FAMOTIDINE 70 70 96 88
PHENYTOIN 68 68 98 257
TRIAMTERENE-HCTZ 68 65 98 48
EVISTA 67 67 100 168
PROBENECID 67 48 100 403
TERAZOSIN HCL 67 53 100 150
DIGOXIN 67 58 100 52
RAMIPRIL 67 33 100 77
MEGESTROL ACETATE 65 65 R 105 134
BETAMETHASONE VALERATE 65 55 105 307
CELEBREX 64 34 107 98
CARISOPRODOL 63 14 R 108 72
ISOSORBIDE MONONITRATE 62 62 109 288
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 38 110 70
LIPITOR 60 51 110 170
DIOVAN 59 35 112 67
CAPTOPRIL 58 58 113 260
SSD 55 52 114 338
QUETIAPINE FUMARATE 55 38 114 75
DILTIAZEM 24HR ER 54 31 116 189
SYNTHROID 54 38 116 91
ENALAPRIL MALEATE 54 43 116 58
LEVETIRACETAM 54 54 116 128
BACLOFEN 52 14 120 129
CARBAMAZEPINE 52 12 120 225
FLUCONAZOLE 52 30 120 102
QUINAPRIL HCL 52 34 120 117
TIZANIDINE HCL 51 33 124 76
ESTRADIOL 51 35 R 124 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.